Cyclicity of breast tenderness and night-time vasomotor symptoms in mid-life women: Information collected using the Daily Perimenopause Diary

Climacteric

Volumn 6, Issue 2, 2003, Pages 128-139

  Hale, G E ^a   Hitchcock, C L ^b   Williams, L A ^c   Vigna, Y M ^b   Prior, J C ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Daily perimenopause diary; Luteal phase length; Mastalgia; Menstrual cycles; Mid life; Ovulation; Quantitative basal temperature; Vasomotor symptoms; Women

Indexed keywords

ADULT; ANOVULATION; ARTICLE; BASAL BODY TEMPERATURE; BREAST TENDERNESS; CIRCADIAN RHYTHM; CLIMACTERIUM; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; FEMALE; HUMAN; LUTEAL PHASE; MASTALGIA; MENOPAUSE; MENSTRUAL CYCLE; OVULATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VASOMOTOR REFLEX;

EID: 0038808613     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.2.128.139     Document Type: Article

References (46)

1. Kaufert PA, Gilbert P, Hassard T. Researching the symptoms of menopause: an exercise in methodology. Maturitas 1988;10:117-31
2. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8
3. Johannes CB, Crawford SL, Longcope C, McKinlay SM. Bleeding patterns and changes in the perimenopause: a longitudinal characterization of menstrual cycles. Clin Consult Obstet Gynecol 1996;8:9-20
4. Grisso JA, Freeman EW, Maurin E, Garcia-Espana B, Berlin JA. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999;14:98-103
5. Tilt EJ. The Change of Life in Health and Disease. A Practical Treatise on the Nervous and other Afflictions Incidental to Women at the Decline of Life, 3rd edn. Philadelphia, PA: Lindsay & Blakiston, 1871
6. Neugarten BL, Kraines RJ. Menopausal symptoms in women of various ages. Psychosom Med 1964;27:266-73
7. Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence of severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. J Am Coll Surg 1997;184:596-604
8. Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol 1997;177:126-32
9. Ayers JWT, Gidwani GP. The 'luteal breast': hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia. Fertil Steril 1983;40:779-83
10. Wang M, Seippel L, Purdy RH, Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione, and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab 1996;81:1076-82
11. Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status, and hormone levels in a population-based sample of mid-life women. Obstet Gynecol 1996;88:437-42
12. Avis NE, Kaufert PA, Lock M, McKinlay SM, Vass K. The evolution of menopausal symptoms. Baillière's Clin Endocrinol Metab 1993;7:17-32
13. Shaver J, Giblin E, Lentz M, Lee K. Sleep patterns and stability in perimenopausal women. Sleep 1988;11:556-61
14. Woods NF, Mitchell ES. Patterns of depressed mood in mid-life women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health 1996;19:111-23
15. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103-15
16. Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992;14:117-26
17. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000;7:334-49
18. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86
19. Casper RF, Graves GR, Reid RL. Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 1987;47:341-4
20. Hahn PM, Wong J, Reid RL. Menopausal-like hot flashes reported in women of reproductive age. Fertil Steril 1998;79:913-18
21. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998;19:397-428
22. Santoro N, Rosenberg J, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-501
23. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-11
24. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia AS, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81:2742-5
25. Prior JC. Ovulatory changes with perimenopause: the ageing female reproductive axis II. In Veldhuis JD, Laron Z, eds. Endocrine Facets of Ageing in the Human and Experimental Animal. London: Wiley Publishers, 2002:172-92
26. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-8
27. Prior JC, Vigna YM, Schulzer M, Hall JE, Bonen A. Determination of luteal phase length by quantitative basal temperature methods: validation against the midcycle LH peak. Clin Invest Med 1990;13:123-31
28. Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-7
29. Prior JC, Vigna YM, Barr SI, Kennedy S, Schulzer M, Li DK. Ovulatory premenopausal women lose cancellous spinal bone: a five year prospective study. Bone 1996;18:261-7
30. Prior JC, Alojado N, McKay DW, Vigna YM. No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, cross-over trial. Obstet Gynecol 1994;83:24-8
31. Prior JC. The Puzzle of Perimenopause - Using the Daily Perimenopause Diary. University of British Columbia, Vancouver, Canada, 1999 [Video, © Prior JC]
32. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002;20:1449-55
33. Vollman RF. The menstrual cycle. In Friedman EA, ed. Major Problems in Obstetrics and Gynecology, 1st edn. Toronto: WB Saunders Company, 1977;7:193pp
34. Prior JC. PMS, perimenopause and ovulation disturbances. Can J CME 1997;May:19-26
35. Prior JC. Premenstrual symptoms and signs. In Rabel RE, Bope ET, eds. Conn's Current Therapy 2002. New York: WB Saunders Company, 2002:1078-80
36. Hammar M, Berg G, Fahraws L, Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas 1984;6:345
37. Kaufert PA, Gilbert P, Tate R. Defining menopausal status: the impact of longitudinal data. Maturitas 1987;9:217-26
38. Stewart DE, Boydell K, Derzko C, Marshall V. Psychological distress during the menopausal years in women attending a menopause clinic. Int J Psychiatr Med 1992;22:213-20
39. Swartzman LC, Edelberg R, Kemmann E. Impact of stress on objectively recorded menopausal hot flushes and on flush report bias. Health Psychol 1990;9:529-45
40. Mitchell ES, Woods NF. Symptom experiences of mid-life women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996;25:1-10
41. Gangar KF, Cust MP, Whitehead MI. Symptoms of oestrogen deficiency associated with supraphysiological plasma estradiol concentrations in women with oestradiol implants. Br Med J 1993;299:601-2
42. Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL. Association of waking episodes with menopausal hot flushes. J Am Med Assoc 1981;245:1741-4
43. Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;65:1141-4
44. Bauman J. Basal body temperature: unreliable method of ovulation detection. Fertil Steril 1981;36:729-33
45. Burch TK, Macisco JJ, Parker MP. Some methodologic problems in the analysis of menstrual data. Int J Fertil 1967;12:67-76
46. Casper RF, Dodin S, Reid RL, Study Investigators. The effect of 20 μg ethinylestradiol/1 mg norethindrone acetate (Minestrin™), a low-dose oral contraceptive, on vaginal bleeding patterns, hot flashes, and quality of life in symptomatic perimenopausal women. Menopause 1997;4:139-47